Zurn Elkay Water Solutions Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZWS research report →
Range $55 – $62
Price Chart
About the company
Zurn Elkay Water Solutions Corporation (ZEWS) is a leading provider of comprehensive water system solutions. The company is involved in the entire lifecycle, from design and procurement to manufacturing and marketing, with a focus on optimizing water quality, safety, flow management, and conservation within and around non-residential structures. ZEWS markets a diverse portfolio of products under several well-known brands.
- CEO
- Todd A. Adams
- IPO
- 2012
- Employees
- 2,600
- HQ
- Milwaukee, WI, US
Get TickerSpark's AI analysis on ZWS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.96B
- P/E
- 29.08
- Fwd P/E
- 26.22
- PEG
- 0.48
- P/S
- 4.58
- P/B
- 4.84
- EV/EBITDA
- 23.02
- Div Yield
- 0.92%
- Gross Margin
- 44.77%
- Op Margin
- 17.44%
- Net Margin
- 15.89%
- ROE
- 17.09%
- ROIC
- 9.25%
Latest fiscal year · YoY change
- Revenue
- $1.70B+8.3%
- Gross Profit
- $706.10M-0.1%
- Op Income
- $288.50M
- Net Income
- $198.00M+23.6%
- EPS
- $1.14+22.6%
- OCF Growth
- +18.1%
- FCF Growth
- +16.5%
- 52W High
- $55.00
- 52W Low
- $43.06
- 50D MA
- $48.51
- 200D MA
- $48.29
- Beta
- 0.77
- RSI (14)
- 58
- Avg Volume
- 896.01K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Zurn Elkay delivered record margins and raised full-year sales, EBITDA, and free cash flow outlook on broad-based growth, strong pricing, and early Intellihot contributions.· July 29, 2026
- Q2 sales were $491 million, up 10% year-over-year, with adjusted EBITDA of $136 million and margin of 27.7%, up 120 bps to a record since the merger.
- Free cash flow was $112 million in the quarter; the company also repurchased $50 million of stock, bringing year-to-date repurchases and investment to $100 million.
- Full-year 2026 guidance was raised to adjusted EBITDA of $503 million-$513 million and free cash flow of at least $350 million, including about $18 million of Intellihot net sales in the last 5 months.
- Management said price contributed about 5% in Q2 and expects 2026 price to be in the 3% to 4% range, while core Q3 sales are guided to 6% to 7% growth and Q3 EBITDA margin around 28%.
- Intellihot was framed as a long-term adjacency with $37 million of sales this year, 50% gross margins, low-teens EBITDA margins, and a path to a $100 million business with 30% EBITDA margins over 5-6 years.
Q2 2026 sales were $491 million, up 10% year-over-year on both a core and reported basis. Adjusted EBITDA was $136 million, and adjusted EBITDA margin was 27.7%, up 120 basis points year-over-year and the highest quarterly margin since the Zurn Elkay merger. In the first half, sales increased by $91 million and EBITDA by $36 million year-over-year, with first-half EBITDA margin at 27.3%, up about 140 basis points. Free cash flow was $112 million in the quarter, and net debt leverage ended at 0.3x, the lowest the company has had as a public company. The company received $48 million in cash from IEEPA and reciprocal tariff refunds in the quarter, including $2 million of accrued interest, but said that item is excluded from adjusted earnings and free cash flow. For Q3 2026, management guided to core sales growth of 6% to 7% and adjusted EBITDA margin around 28%. For full-year 2026, it now expects adjusted EBITDA of $503 million-$513 million and free cash flow of at least $350 million, excluding any past or future tariff refunds. Management also said Intellihot should contribute approximately $18 million in net sales in the last 5 months of the year.
Todd Adams emphasized that the quarter reflected the compounding benefits of years of product focus, operational improvements, and supply chain work. He highlighted that the company is gaining share in higher-margin categories, pruning lower-value businesses through 80/20, and using the Zurn Elkay business system to keep expanding margins and cash flow. On Intellihot, he described the deal as a long-coveted adjacency, saying the company will invest for the long term and pursue a path to a much larger business rather than optimize for next year.
Dan Klun focused on the financial outperformance and balance sheet strength. He cited Q2 sales of $491 million, adjusted EBITDA of $136 million, margin of 27.7%, $112 million of quarterly free cash flow, and net leverage of 0.3x. He also noted the $48 million tariff refund cash receipt, explained it is non-recurring and excluded from adjusted results, and said $6 million of IEEPA and reciprocal tariff amounts remained uncollected and unrecognized at June 30. He reiterated the updated 2026 outlook and said the D&A guidance does not yet include the incremental Intellihot purchase accounting impact.
Analysts pressed on pricing, Intellihot, margin expansion, and the durability of growth. Management said the 5% Q2 price benefit was largely from prior tariff-related actions, not new price increases, and said 2026 should look like a normal pricing year at 3% to 4%. On Intellihot, they said the business has strong technology, regulatory tailwinds, and channel fit, and that Zurn Elkay expects to use its specification, contractor, wholesaler, and sourcing capabilities to expand share over time. When asked about incremental margin guidance, management said the current 40% level is a reasonable snapshot given the mix of higher-growth, higher-margin products and operating leverage.
The bullish case is that Zurn Elkay is still growing above market while expanding margins to record levels. Management pointed to strong momentum in drinking water, water safety and control, and flow systems, plus a new adjacency in Intellihot with attractive gross margins and a long runway. The company also has strong cash generation, low leverage, and ongoing share repurchases.
The main risks discussed were softness in residential and some commercial pockets, plus the fact that Q3 and second-half growth should slow as tariff-related price actions lap. Intellihot is still early and management acknowledged there is integration work to do and that meaningful scaling will take time. They also noted the category remains competitive and that some parts of the portfolio may still face 80/20 pruning decisions.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.6%
- Shares Outstanding
- 165.86M
- Float Shares
- 147.00M
Buy/sell ratio 6.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 26 | Butler Jacques Donavon | buy | 2,016 |
| Aug 4, 26 | PETERSON MARK W | sell | 25,000 |
| Jul 23, 26 | Hersil Angela M | other | 0 |
| Jul 23, 26 | Hersil Angela M | other | 0 |
| Jul 23, 26 | Hersil Angela M | other | 6,278 |
| Jul 23, 26 | Hersil Angela M | other | 3,836 |
| Jul 23, 26 | Hersil Angela M | other | 2,679 |
| Jul 23, 26 | Hersil Angela M | other | 3,639 |
| Jul 23, 26 | Hersil Angela M | other | 1,816 |
| Jul 23, 26 | Hersil Angela M | other | 1,673 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ZWS coverage
Recent articles, reports, and earnings notes.
No research on ZWS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZWS report →